182 related articles for article (PubMed ID: 19778427)
1. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
2. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
3. Solitary plasmacytoma of bone: clinical features, treatment and survival.
Ellis PA; Colls BM
Hematol Oncol; 1992; 10(3-4):207-11. PubMed ID: 1398516
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
5. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
7. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.
Jawad MU; Extein J; Min ES; Scully SP
Clin Orthop Relat Res; 2009 Nov; 467(11):2939-48. PubMed ID: 19224301
[TBL] [Abstract][Full Text] [Related]
11. Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.
Shen X; Liu S; Wu C; Wang J; Li J; Chen L
Cancer Med; 2021 Jan; 10(2):462-470. PubMed ID: 33145987
[TBL] [Abstract][Full Text] [Related]
12. Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases.
Venkatesulu B; Mallick S; Giridhar P; Upadhyay AD; Rath GK
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):595-606. PubMed ID: 29224044
[TBL] [Abstract][Full Text] [Related]
13. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli MA; Russo D; Petrucci MT; Bucalossi A; Tura S
Ann Oncol; 1995 Sep; 6(7):687-91. PubMed ID: 8664190
[TBL] [Abstract][Full Text] [Related]
14. Solitary Plasmacytoma of Bone of the Spine: Results From Surveillance, Epidemiology, and End Results (SEER) Registry.
Wang Y; Li H; Liu C; Chen C; Yan J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E117-E125. PubMed ID: 30005040
[TBL] [Abstract][Full Text] [Related]
15. Oncologic progression of bone plasmacytomas to multiple myeloma.
Bertanha F; Boufelli G; de Camargo OP; Baptista AM; Caiero MT; de Oliveira CR; Filippi R
Clinics (Sao Paulo); 2006 Apr; 61(2):139-46. PubMed ID: 16680331
[TBL] [Abstract][Full Text] [Related]
16. Does Radiotherapy with Surgery Improve Survival and Decrease Progression to Multiple Myeloma in Patients with Solitary Plasmacytoma of Bone of the Spine?
Xie L; Wang H; Jiang J
World Neurosurg; 2020 Feb; 134():e790-e798. PubMed ID: 31715413
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.
Barzenje DA; Kolstad A; Ghanima W; Holte H
Hematol Oncol; 2018 Feb; 36(1):217-223. PubMed ID: 28393375
[TBL] [Abstract][Full Text] [Related]
18. Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Paiva B; Chandia M; Vidriales MB; Colado E; Caballero-Velázquez T; Escalante F; Garcia de Coca A; Montes MC; Garcia-Sanz R; Ocio EM; Mateos MV; San Miguel JF
Blood; 2014 Aug; 124(8):1300-3. PubMed ID: 24876564
[TBL] [Abstract][Full Text] [Related]
19. Solitary plasmacytoma: experiences from Central Anatolia.
Coskun HS; Er O; Soyuer S; Altinbas M; Eser B; Karahacioglu E; Altuntas F
Ir J Med Sci; 2005; 174(1):33-6. PubMed ID: 15868887
[TBL] [Abstract][Full Text] [Related]
20. Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.
Avivi I; Cohen YC; Suska A; Shragai T; Mikala G; Garderet L; Seny GM; Glickman S; Jayabalan DS; Niesvizky R; Gozzetti A; Wiśniewska-Piąty K; Waszczuk-Gajda A; Usnarska-Zubkiewicz L; Hus I; Guzicka R; Radocha J; Milunovic V; Davila J; Gentile M; Castillo JJ; Jurczyszyn A
Am J Hematol; 2019 Oct; 94(10):1132-1140. PubMed ID: 31334859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
